In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients

DENG, S.; DE HOOG, G.; VERWEIJ, P.; ZOLL, J.; İLKİT, MEHMET; MORSALI, F.; Abliz, P.; Wang, X.; ZHAN, P.; YANG, L.; Hasimu, H.; LIAO, W.; PAN, W.; SEYEDMOUSAVI, S.

doi:10.1093/jac/dku503

In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients

Atıf İçin Kopyala

DENG S., DE HOOG G. S., VERWEIJ P. E., ZOLL J., İLKİT M. M., MORSALI F., ...Daha Fazla

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.70, sa.4, ss.1072-1075, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 70 Sayı: 4
Basım Tarihi: 2015
Doi Numarası: 10.1093/jac/dku503
Dergi Adı: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1072-1075
Anahtar Kelimeler: T. violaceum, antifungal susceptibility testing, fungus, CLINICAL-TRIAL, WESTERN CHINA, DERMATOPHYTES, GRISEOFULVIN, TERBINAFINE, FLUCONAZOLE, DRUGS
Çukurova Üniversitesi Adresli: Evet

Özet

Objectives: Trichophyton violaceum is an anthropophilic dermatophyte that is endemic to parts of Africa and Asia and is sporadic in Europe. T. violaceum mainly causes tinea capitis in both children and adolescents. Although the infections caused by T. violaceum are of considerable medical importance, its antifungal susceptibility profile remains poorly examined.